R. Pete Vanderveen, PhD, RPh
Clinical Pharmacy and Pharmaceutical Economics & Policy
Phone: (323) 442-1369
Fax: (323) 442-1681
R. Pete Vanderveen, PhD, RPh, assumed the position of Dean of the USC School of Pharmacy in September 2005. Dr. Vanderveen has held a number of other academic posts, practiced pharmacy in diverse settings, was Board Certified as a Psychiatric Pharmacy Practitioner and published on pharmacy topics throughout his career. He recently penned an op-ed in The Wall Street Journal that was a call to action to fundamentally change pharmacy practice with pharmacists taking a proactive stance on collaborative medication therapy management.
Prior to joining USC, Dr. Vanderveen was Dean of the Mylan School of Pharmacy at Duquesne University. During his tenure, the Mylan School rose to third in the nation in NIH funding among private schools of pharmacy, doubled enrollment in MS and PhD programs, and became the first school in the nation to offer the Weekend PharmD program. Before joining Duquesne, Dr. Vanderveen served as Assistant Dean for Pharmacy Practice at Oregon State University, successfully implementing their first PharmD program.
Since his arrival at USC, Dr. Vanderveen has been instrumental in expanding the school’s work in providing care to underserved communities in the Los Angeles area. The School’s innovative practice model where faculty and students serve patients in safety-net clinics has been pioneering, and produced stellar results – improving health outcomes while saving health-care dollars. In recognition of this work under Dr. Vanderveen’s leadership, the USC School of Pharmacy was won the American Pharmacists Association Pinnacle Award, the American Society of Health System Pharmacists Best Practices Award and the American Association of Colleges of Pharmacy Inaugural Award for Transformative Community Service.
Under Dr. Vanderveen's leadership, the School has enhanced its research infrastructure, enriching opportunities for scientists to pursue a broad range of projects addressing pressing health issues, especially in drug development, design, targeting and delivery. Dr. Vanderveen was also instrumental in establishing the nationally recognized Schaeffer Center for Health Policy and Economics, a collaboration with the School of Policy, Planning and Development.
Since 2002, Dr. Vanderveen has served on the Board of Directors of Mylan Pharmaceuticals, where he chairs the independent company directors. Dr. Vanderveen earned BS and MS degrees in pharmacy and clinical pharmacy, respectively, from Purdue University in the 1970s. He earned his doctorate in university administration from Michigan State University in 1987 and graduated from the AACP Leadership Development Program in Duke University’s Fuqua School of Business in 1998.